Indications and uses
acid indigestion heartburn sour stomach upset stomach due to these symptoms pressure and bloating commonly referred to as gas
acid indigestion heartburn sour stomach upset stomach due to these symptoms pressure and bloating commonly referred to as gas
shake well before using do not take more than 8 teaspoonfuls in 24 hours or use the maximum dosage for more than 2 weeks adults and children 12 years and older take 2 to 4 teaspoonfuls two times a day or as directed by a physician children under 12 years consult a physician
each 5 mL contains: magnesium 167 mg, sodium 2.24 mg store at controlled room temperature 20° - 25°C (68° - 77°F) [see USP Controlled Room Temperature]. protect from freezing White colored, cherry flavored liquid supplied in the following oral dosage form: NDC 0121-1762-30: 30 mL unit dose cup. Case contains 100 unit dose cups of 30 mL packaged in 10 trays of 10 unit dose cups each. *Maalox is a registered tradema...
Drug Facts
| Active ingredients (in each 5 mL = 1 teaspoonful) | Purpose |
|---|---|
| Aluminum hydroxide (equiv. to dried gel, USP) 400 mg | Antacid |
| Magnesium hydroxide 400 mg | Antacid |
| Simethicone 40 mg | Antigas |
Do not take more than 8 teaspoonfuls in a 24-hour period or use the maximum dosage for more than 2 weeks except under the advice and supervision of a physician.
Keep out of reach of children.
| adults and children 12 years and older | take 2 to 4 teaspoonfuls two times a day or as directed by a physician |
| children under 12 years | consult a physician |
NDC 0121-1762-30: 30 mL unit dose cup. Case contains 100 unit dose cups of 30 mL packaged in 10 trays of 10 unit dose cups each.
*Maalox is a registered trademark of Novartis Consumer Health, Inc.
Butylparaben, hydroxypropyl methylcellulose, flavoring, propylene glycol, propylparaben, purified water, sodium saccharin, and sorbitol solution.
MANUFACTURED BY
Pharmaceutical
Associates, Inc.
Greenville, SC 29605
www.paipharma.com
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 237870 | aluminum hydroxide 400 MG / magnesium hydroxide 400 MG / simethicone 40 MG in 5 mL Oral Suspension | PSN | 8 |
| 237870 | aluminum hydroxide 80 MG/ML / magnesium hydroxide 80 MG/ML / simethicone 8 MG/ML Oral Suspension | SCD | 8 |
| 237870 | aluminum hydroxide 2400 MG / magnesium hydroxide 2400 MG / dimethicone 240 MG per 30 ML Oral Suspension | SY | 8 |
| 237870 | aluminum hydroxide 400 MG / magnesium hydroxide 400 MG / simethicone 40 MG per 5 ML Oral Suspension | SY | 8 |
| 237870 | aluminum hydroxide 800 MG / magnesium hydroxide 800 MG / dimethicone 80 MG per 10 ML Oral Suspension | SY | 8 |
| Class | Version | Type | Effective |
|---|---|---|---|
| DIMETHICONE Pharmacologic Class Indexing | 3 | Indexing - Pharmacologic Class | 20180813 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0121-1762-30 | Mag-AL PlusXS | 10 in 1 TRAY | SUSPENSION | 10 | 8 | |
| 0121-1762-30 | Mag-AL PlusXS | 10 in 1 CASE | SUSPENSION | 10 | 8 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 0121-1762 | MAG-AL PLUS XS (ALUMINUM HYDROXIDE, MAGNESIUM HYDROXIDE, AND DIMETHICONE) SUSPENSION [PAI HOLDINGS, LLC DBA PAI PHARMA] | 8 | Current NDC, Legacy NDC, 2 package rows | 20241114_db0c47ab-5296-4195-9fa6-2e338b665094.zip |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0121-1762-30 | ML - Milliliter | 0121-1762 | 15a221d5-f2b9-4738-a87a-18544a2c7c71 | 1 | 2014-10-03 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Aluminum Hydroxide | ACTIVE INGREDIENT | 5QB0T2IUN0 | 1 | |
| Dimethicone | ACTIVE INGREDIENT | 92RU3N3Y1O | 1 | |
| Magnesium Hydroxide | ACTIVE INGREDIENT | NBZ3QY004S | 1 | |
| Aluminum Hydroxide | ACTIVE MOIETY | 5QB0T2IUN0 | 1 | |
| Dimethicone | ACTIVE MOIETY | 92RU3N3Y1O | 1 | |
| Hydroxide Ion | ACTIVE MOIETY | 9159UV381P | 1 | |
| Butylparaben | INACTIVE INGREDIENT | 3QPI1U3FV8 | 1 | |
| Cyclomethicone 4 | INACTIVE INGREDIENT | CZ227117JE | 1 | |
| Hypromellose 2910 (4000 mpa.s) | INACTIVE INGREDIENT | RN3152OP35 | 1 | |
| Peppermint Oil | INACTIVE INGREDIENT | AV092KU4JH | 1 | |
| Propylene Glycol | INACTIVE INGREDIENT | 6DC9Q167V3 | 1 | |
| Propylparaben | INACTIVE INGREDIENT | Z8IX2SC1OH | 1 | |
| Saccharin Sodium | INACTIVE INGREDIENT | SB8ZUX40TY | 1 | |
| Sorbitol | INACTIVE INGREDIENT | 506T60A25R | 1 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 0121-1762 | 0121-1762-30 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| ALUMINUM HYDROXIDE | 5QB0T2IUN0 | ACTIB |
| MAGNESIUM HYDROXIDE | NBZ3QY004S | ACTIB |
| DIMETHICONE | 92RU3N3Y1O | ACTIB |
| BUTYLPARABEN | 3QPI1U3FV8 | IACT |
| PROPYLPARABEN | Z8IX2SC1OH | IACT |
| HYPROMELLOSE 2910 (4000 MPA.S) | RN3152OP35 | IACT |
| PROPYLENE GLYCOL | 6DC9Q167V3 | IACT |
| SORBITOL | 506T60A25R | IACT |
| SACCHARIN SODIUM | SB8ZUX40TY | IACT |
| PEPPERMINT OIL | AV092KU4JH | IACT |
| CYCLOMETHICONE 4 | CZ227117JE | IACT |
| WATER | 059QF0KO0R | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Propylparaben | PROPYLPARABEN | Z8IX2SC1OH | SUSPENSION / ORAL | 64 mg | ||
| Saccharin Sodium | SACCHARIN SODIUM | SB8ZUX40TY | SUSPENSION / ORAL | 5000 mg/5ml | ||
| Butylparaben | BUTYLPARABEN | 3QPI1U3FV8 | SUSPENSION / ORAL | 12 mg | ||
| Propylparaben | PROPYLPARABEN | Z8IX2SC1OH | SUSPENSION / ORAL | 64 mg | ||
| Saccharin Sodium | SACCHARIN SODIUM | SB8ZUX40TY | SUSPENSION / ORAL | 5000 mg/5ml | ||
| Sorbitol | SORBITOL | 506T60A25R | SUSPENSION / ORAL | 45000 mg | ||
| Butylparaben | BUTYLPARABEN | 3QPI1U3FV8 | SUSPENSION / ORAL | 12 mg | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | SUSPENSION / ORAL | 27120 mg | ||
| Sorbitol | SORBITOL | 506T60A25R | SUSPENSION / ORAL | 45000 mg | ||
| Hypromellose 2910 (4000 mpa.s) | HYPROMELLOSE 2910 (4000 MPA.S) | RN3152OP35 | SUSPENSION / ORAL | 360 mg | ||
| Peppermint Oil | PEPPERMINT OIL | AV092KU4JH | SUSPENSION / ORAL | 100 mg/1ml | ||
| Hypromellose 2910 (4000 mpa.s) | HYPROMELLOSE 2910 (4000 MPA.S) | RN3152OP35 | SUSPENSION / ORAL | 360 mg | ||
| Peppermint Oil | PEPPERMINT OIL | AV092KU4JH | SUSPENSION / ORAL | 100 mg/1ml | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | SUSPENSION / ORAL | 27120 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Mag-AL Plus XS | ALUMINUM HYDROXIDE, MAGNESIUM HYDROXIDE, AND DIMETHICONE | PAI Holdings, LLC dba PAI Pharma | db0c47ab-5296-4195-9fa6-2e338b665094 | 2024-11-12 | Warnings | 0121-1762-30 0121-1762 00121176230 b950b648-4292-4b99-ad30-52f554434f27 db0c47ab-5296-4195-9fa6-2e338b665094 |
Adverse event summaries are temporarily unavailable. Other product information remains available.